Abstract:Background Patients with metal-on-metal hip replacements require testing for cobalt and chromium. There may also be a need to test for titanium, which is used in the construction of the femoral stem in total hip replacements. It is not possible to use quadrupole inductively coupled plasma mass spectrometry due to interferences. Methods Titanium was measured using inductively coupled plasma optical emission spectroscopy using the emission line at 336.1 nm and Y (internal standard) at 371.0 nm. Internal quality … Show more
“…As a result, they are not widely available in routine clinical laboratories. Inductively coupled plasma optical emission spectroscopy (ICP-OES) could be a more practical and cost-effective solution [89]. The method displayed a low detection limit for the determination of titanium concentration in the serum (0.6 µg L -1 ) [89], plasma (1.6 µg L -1 ) [90] and periprosthetic tissue (3.0 µg g -1 ) [91] of patients with MoM hips.…”
Section: Measurement Of Titanium In Biological Samplesmentioning
Background: Joint replacement implants are usually manufactured from cobalt-chromium or titanium alloys. After the device is implanted, wear and corrosion generate metal particles and ions, which are released into local tissue and blood. The metal debris can cause a range of adverse local and systemic effects in patients. Research problem: In the case of cobalt and chromium, a blood level exceeding 7 µg L-1 indicates potential for local toxicity, and a failing implant. It has been repeatedly suggested in the literature that measurement of titanium could also be used to assess implant function. Despite an increasing interest in this biomarker, and growing use of titanium in orthopaedics, it is unclear what blood concentrations should raise concerns. This is partly due to the technical challenges involved in the measurement of titanium in biological samples. Aim: This Review summarises blood/serum titanium levels associated with well-functioning and malfunctioning prostheses, so that the prospects of using titanium measurements to gain insights into implant performance can be evaluated. Conclusion: Due to inter-laboratory analytical differences, reliable conclusions regarding "normal" and "abnormal" titanium levels in patients with orthopaedic implants are difficult to draw. Diagnosis of symptomatic patients should be based on radiographic evidence combined with blood/serum metal levels.
“…As a result, they are not widely available in routine clinical laboratories. Inductively coupled plasma optical emission spectroscopy (ICP-OES) could be a more practical and cost-effective solution [89]. The method displayed a low detection limit for the determination of titanium concentration in the serum (0.6 µg L -1 ) [89], plasma (1.6 µg L -1 ) [90] and periprosthetic tissue (3.0 µg g -1 ) [91] of patients with MoM hips.…”
Section: Measurement Of Titanium In Biological Samplesmentioning
Background: Joint replacement implants are usually manufactured from cobalt-chromium or titanium alloys. After the device is implanted, wear and corrosion generate metal particles and ions, which are released into local tissue and blood. The metal debris can cause a range of adverse local and systemic effects in patients. Research problem: In the case of cobalt and chromium, a blood level exceeding 7 µg L-1 indicates potential for local toxicity, and a failing implant. It has been repeatedly suggested in the literature that measurement of titanium could also be used to assess implant function. Despite an increasing interest in this biomarker, and growing use of titanium in orthopaedics, it is unclear what blood concentrations should raise concerns. This is partly due to the technical challenges involved in the measurement of titanium in biological samples. Aim: This Review summarises blood/serum titanium levels associated with well-functioning and malfunctioning prostheses, so that the prospects of using titanium measurements to gain insights into implant performance can be evaluated. Conclusion: Due to inter-laboratory analytical differences, reliable conclusions regarding "normal" and "abnormal" titanium levels in patients with orthopaedic implants are difficult to draw. Diagnosis of symptomatic patients should be based on radiographic evidence combined with blood/serum metal levels.
“…Examination of removed devices suggests that there are problems associated with the titanium alloy stem that goes into the femoral bone. Blood samples were collected from 39 subjects aged 18 to 74 years and 65 Cu : 63 Cu and 66 Zn : 64 Zn ratios measured, obtaining results that were consistent with the animal ndings. Determination of Ti by Q-ICP-MS is complicated by isobaric interferences from the relatively huge concentrations of Ca isotopes.…”
Section: Investigations Of Metallic Implants and Biomaterialsmentioning
confidence: 64%
“…Fe Exhaled air ICP-MS As part of an investigation of potential biomarkers of exposure to welding fumes, the content of Fe and Mn in endogenous particles in exhaled air was determined by ICP-MS in samples collected from 9 individuals, experimentally exposed to welding fumes, revealing increased mean concentrations of Mn (82-84 pg L À1 ) and Fe (2600 pg L À1 ) in exhaled air Blood, plasma ICP-MS Mn concentrations were determined in blood and serum samples aer dilution with a solution of 0.005% Triton X-100-0.2% propan-2-ol-0.2% butan-1-ol-1% HNO 3 and addition of Ga as the internal standard. Several isotopes were monitored simultaneously ( 13 C, 111 Cd, 112 Cd, 114 Cd, 63 Cu, 56 Fe, 57 Fe, 31 P, 34 From starting conditions which completely digested 500 mg of sample (whole milk powder or bovine liver) using dilute HNO 3 and O 2 (7.5 or 5.0 bar), the authors optimised concentrations to give minimal residual carbon content (RCC) and residual acid (RA). Recovery of spiked amounts of all analytes at different concentration levels was >87% and RSDs were between 2% and 7%.…”
Section: Digestion Extraction and Preconcentrationmentioning
confidence: 99%
“…Harrington et al63 The use of collision reaction cell with ICP-MS is well established and has been used to solve a number of challenges.…”
A theme that emerges from this year's Update is that of 'green' chemistry. This, in part, explains the larger than usual number of publications focussing on sample preparation, especially those concerned with the analysis of foods. Procedures that involved dilute acids while still achieving digestion of the specimens were Cite this:
“…Titanium ions associate with plasma proteins [37], which accounts for the higher titanium 34 content of plasma compared to whole blood [38]. Serum/plasma sampling is preferred by 35 some researchers, because the higher titanium levels are easier to detect and quantify.…”
Section: Whole Blood Versus Plasma/serum Sampling 33mentioning
Background: Hip implants are usually manufactured from cobalt-chromium and titanium alloys. As the implants wear and corrode, metal debris is released into the surrounding tissue and blood, providing a potential biomarker for their function. Whilst there are laboratory reference levels for blood cobalt and chromium in patients with well and poorly functioning hip implants, there are no such guidelines for titanium. This is despite the increasing use of titanium implants worldwide. Patients and methods: We recruited a consecutive series of 95 patients (mean age 71 years, mean time after surgery 8.5 years) with one hip implant type, inserted by the same surgeon. We assessed clinical and radiological outcome, and measured blood and plasma titanium using high resolution inductively-coupled plasma mass spectrometry. Results: The upper normal reference limit for blood and plasma titanium was 2.20 and 2.56 g L-1 , respectively, and did not differ significantly between males and females. Conclusion: We are the first to propose a laboratory reference level for blood and plasma titanium in patients with well-functioning titanium hip implants. This is an essential starting point for further studies to explore the clinical usefulness of blood titanium as a biomarker of orthopaedic implant performance, and comes at a time of considerable controversy regarding the use of certain titanium alloys in hip arthroplasty.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.